BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 26472403)

  • 1. TERT promoter mutations in periocular carcinomas: implications of ultraviolet light in pathogenesis.
    Lin SY; Liao SL; Hong JB; Chu CY; Sheen YS; Jhuang JY; Tsai JH; Liau JY
    Br J Ophthalmol; 2016 Feb; 100(2):274-7. PubMed ID: 26472403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent TERT Promoter Mutations in Ocular Surface Squamous Neoplasia.
    Scholz SL; Thomasen H; Reis H; Möller I; Darawsha R; Müller B; Dekowski D; Sucker A; Schilling B; Schadendorf D; Steuhl KP; Paschen A; Westekemper H; Meller D; Griewank KG
    Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):5854-61. PubMed ID: 26348634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinoma.
    Griewank KG; Murali R; Schilling B; Schimming T; Möller I; Moll I; Schwamborn M; Sucker A; Zimmer L; Schadendorf D; Hillen U
    PLoS One; 2013; 8(11):e80354. PubMed ID: 24260374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of TERT promoter mutations status in squamous cell carcinomas of different anatomical sites.
    Cheng KA; Kurtis B; Babayeva S; Zhuge J; Tantchou I; Cai D; Lafaro RJ; Fallon JT; Zhong M
    Ann Diagn Pathol; 2015 Jun; 19(3):146-8. PubMed ID: 25862495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions.
    Koopmans AE; Ober K; Dubbink HJ; Paridaens D; Naus NC; Belunek S; Krist B; Post E; Zwarthoff EC; de Klein A; Verdijk RM;
    Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):6024-30. PubMed ID: 25159205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypermethylation of the CDKN2A gene promoter is a frequent epigenetic change in periocular sebaceous carcinoma and is associated with younger patient age.
    Liau JY; Liao SL; Hsiao CH; Lin MC; Chang HC; Kuo KT
    Hum Pathol; 2014 Mar; 45(3):533-9. PubMed ID: 24440092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic inactivation of the E-cadherin gene in eyelid sebaceous gland carcinoma.
    Jayaraj P; Sen S; Sharma A; Chosdol K; Kashyap S; Rai A; Pushker N; Bajaj MS; Ghose S
    Br J Dermatol; 2012 Sep; 167(3):583-90. PubMed ID: 22458737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomerase promoter mutations in human immunodeficiency virus-related conjunctiva neoplasia.
    Starita N; Buonaguro L; Buonaguro FM; Tornesello ML
    J Transl Med; 2018 Mar; 16(1):77. PubMed ID: 29562930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of patients with periocular sebaceous gland carcinoma with and without conjunctival intraepithelial invasion.
    Chao AN; Shields CL; Krema H; Shields JA
    Ophthalmology; 2001 Oct; 108(10):1877-83. PubMed ID: 11581065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TERT promoter mutation is uncommon in acral lentiginous melanoma.
    Liau JY; Tsai JH; Jeng YM; Chu CY; Kuo KT; Liang CW
    J Cutan Pathol; 2014 Jun; 41(6):504-8. PubMed ID: 24588324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas.
    Bolshakov S; Walker CM; Strom SS; Selvan MS; Clayman GL; El-Naggar A; Lippman SM; Kripke ML; Ananthaswamy HN
    Clin Cancer Res; 2003 Jan; 9(1):228-34. PubMed ID: 12538474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TERT promoter mutations in skin cancer: the effects of sun exposure and X-irradiation.
    Pópulo H; Boaventura P; Vinagre J; Batista R; Mendes A; Caldas R; Pardal J; Azevedo F; Honavar M; Guimarães I; Manuel Lopes J; Sobrinho-Simões M; Soares P
    J Invest Dermatol; 2014 Aug; 134(8):2251-2257. PubMed ID: 24691053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of SDHD promoter mutations in various types of melanoma.
    Scholz SL; Horn S; Murali R; Möller I; Sucker A; Sondermann W; Stiller M; Schilling B; Livingstone E; Zimmer L; Reis H; Metz CH; Zeschnigk M; Paschen A; Steuhl KP; Schadendorf D; Westekemper H; Griewank KG
    Oncotarget; 2015 Sep; 6(28):25868-82. PubMed ID: 26327518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pathology of skin neoplasms of the head and neck.
    Kraft S; Granter SR
    Arch Pathol Lab Med; 2014 Jun; 138(6):759-87. PubMed ID: 24878016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical and mutational status of telomerase reverse transcriptase in conjunctival squamous cell carcinoma.
    Jayaraj P; Sen S; Saxena K; Gupta J; Vats P; Kashyap S; Chauhan S; Pushker N
    Indian J Ophthalmol; 2022 Mar; 70(3):971-975. PubMed ID: 35225554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TERT promoter hot spot mutations are frequent in Indian cervical and oral squamous cell carcinomas.
    Vinothkumar V; Arunkumar G; Revathidevi S; Arun K; Manikandan M; Rao AK; Rajkumar KS; Ajay C; Rajaraman R; Ramani R; Murugan AK; Munirajan AK
    Tumour Biol; 2016 Jun; 37(6):7907-13. PubMed ID: 26700669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations of the TERT promoter are common in basal cell carcinoma and squamous cell carcinoma.
    Scott GA; Laughlin TS; Rothberg PG
    Mod Pathol; 2014 Apr; 27(4):516-23. PubMed ID: 24030752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TERT promoter mutations are associated with poor prognosis in cutaneous squamous cell carcinoma.
    Campos MA; Macedo S; Fernandes M; Pestana A; Pardal J; Batista R; Vinagre J; Sanches A; Baptista A; Lopes JM; Soares P
    J Am Acad Dermatol; 2019 Mar; 80(3):660-669.e6. PubMed ID: 30165166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma.
    Griewank KG; Murali R; Puig-Butille JA; Schilling B; Livingstone E; Potrony M; Carrera C; Schimming T; Möller I; Schwamborn M; Sucker A; Hillen U; Badenas C; Malvehy J; Zimmer L; Scherag A; Puig S; Schadendorf D
    J Natl Cancer Inst; 2014 Sep; 106(9):. PubMed ID: 25217772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomerase reverse transcriptase (TERT) promoter mutation analysis of benign, malignant and reactive urothelial lesions reveals a subpopulation of inverted papilloma with immortalizing genetic change.
    Cheng L; Davidson DD; Wang M; Lopez-Beltran A; Montironi R; Wang L; Tan PH; MacLennan GT; Williamson SR; Zhang S
    Histopathology; 2016 Jul; 69(1):107-13. PubMed ID: 26679899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.